FDA Drug Approval, N018927, TEGRETOL
FDA Drug Approval, N018927, TEGRETOL
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018927
Company: NOVARTIS
Drug Name: TEGRETOL
Active Ingredients: CARBAMAZEPINE
Strength: 100MG/5ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 12/18/1987
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: NOVARTIS
Drug Name: TEGRETOL
Active Ingredients: CARBAMAZEPINE
Strength: 100MG/5ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 12/18/1987
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details